SEC Insider Transactions from Squarer Ron.

Last updated: 2026-03-14 11:39 UTC | Total transactions: 10

Squarer Ron has filed 10 insider transactions across 3 companies since May 2024.

Most recent transaction: a grant/award of 4418 shares of Nuvalent, Inc. ($NUVL) on December 10, 2025.

Activity breakdown: 0 open-market purchases and 1 sale.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Dec. 10, 2025 Nuvalent, Inc. $NUVL Squarer Ron Not found A Stock Option (Right to Buy) 4418 $0.00 4,418.0000 72,143,466 9999.99% 0.01%
Dec. 10, 2025 Nuvalent, Inc. $NUVL Squarer Ron Not found A Class A Common Stock 2837 $0.00 2,837.0000 72,143,466 9999.99% 0.00%
June 13, 2025 ADC Therapeutics SA $ADCT Squarer Ron Director F Common Shares 15184 $3.58 93,627.0000 97,159,966 13.95% 0.02%
June 3, 2025 ADC Therapeutics SA $ADCT Squarer Ron Director A Common Shares 40000 $0.00 108,811.0000 97,159,966 58.13% 0.04%
May 15, 2025 Travere Therapeutics, Inc. $TVTX Squarer Ron Not found A Common Stock 6500 $0.00 35,375.0000 78,888,861 22.51% 0.01%
May 15, 2025 Travere Therapeutics, Inc. $TVTX Squarer Ron Not found A Stock option (right to buy) 19500 $0.00 19,500.0000 78,888,861 9999.99% 0.02%
June 17, 2024 ADC Therapeutics SA $ADCT Squarer Ron Director S Common Shares 6995 $2.89 80,663.0000 81,712,166 7.98% 0.01%
June 13, 2024 ADC Therapeutics SA $ADCT Squarer Ron Director A Common Shares 40000 $0.00 87,658.0000 81,712,166 83.93% 0.05%
May 8, 2024 Travere Therapeutics, Inc. $TVTX Squarer Ron Not found A Stock option (right to buy) 19500 $0.00 19,500.0000 74,267,418 9999.99% 0.03%
May 8, 2024 Travere Therapeutics, Inc. $TVTX Squarer Ron Not found A Common Stock 6500 $0.00 28,875.0000 74,267,418 29.05% 0.01%